ADC Bio: Sterling Pharma confirms acquisition of UK ADC specialist
Sterling Pharma Solutions, a global contract development and manufacturing organization (CDMO), has acquired ADC Biotechnology (ADC Bio), a UK based company specializing in antibody-drug conjugates (ADCs).
Read full article »
ADC Bio is a UK-based biotechnology company that develops and commercializes antibody-drug conjugates for the treatment of cancer.
Read more